Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
BIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
-1.77%148.620.7%$2321.13m
MDTMedtronic Plc
1.01%113.510.6%$514.20m
TMOThermo Fisher Scientific, Inc.
0.32%320.391.0%$375.93m
ABTAbbott Laboratories
0.41%86.320.8%$369.56m
ISRGIntuitive Surgical, Inc.
-0.23%579.652.4%$319.98m
BDXBecton, Dickinson & Co.
1.25%268.751.1%$312.55m
EWEdwards Lifesciences Corp.
0.87%232.711.2%$295.04m
SYKStryker Corp.
1.52%202.811.3%$269.86m
BSXBoston Scientific Corp.
0.90%45.071.1%$257.49m
DXCMDexCom, Inc.
0.91%203.838.3%$200.85m
BAXBaxter International, Inc.
0.54%83.961.8%$199.13m
MTDMettler-Toledo International, Inc.
-0.77%769.445.4%$162.26m
PODDInsulet Corp.
1.37%175.656.7%$151.28m
ABMDABIOMED, Inc.
1.51%181.853.3%$148.21m
ALGNAlign Technology, Inc.
-0.87%266.066.4%$145.91m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.